Sodium Channels and Pain
Human and mouse genetic studies have led to significant advances in our understanding of the role of voltage-gated sodium channels in pain pathways. In this chapter, we focus on Nav1.7, Nav1.8, Nav1.9 and Nav1.3 and describe the insights gained from the detailed analyses of global and conditional transgenic Nav knockout mice in terms of pain behaviour. The spectrum of human disorders caused by mutations in these channels is also outlined, concluding with a summary of recent progress in the development of selective Nav1.7 inhibitors for the treatment of pain.
KeywordsVoltage-gated sodium channels Channelopathy Transgenic mice Analgesia Chronic pain Sensory neurons
- Estacion M, Dib-Hajj SD et al (2008) NaV1.7 gain-of-function mutations as a continuum: A1632E displays physiological changes associated with erythromelalgia and paroxysmal extreme pain disorder mutations and produces symptoms of both disorders. J Neurosci 28(43):11079–11088CrossRefPubMedGoogle Scholar
- Minett MS, Quick K, Wood JN (2011) Behavioral measures of pain thresholds. In: Auwerx J, Brown SD, Justice M, Moore DD, Ackerman SL, Nadeau J (eds) Current protocols in mouse biology. Wiley, HobokenGoogle Scholar